MERRIMACK PHARMACEUTICALS INC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Mar 4, 2016
Insider Transaction Report
Form 4
PORTER MICHAEL E
Director
Transactions
- Purchase
Common Stock
2016-03-03$6.27/sh+10,000$62,700→ 734,448 total - Purchase
Common Stock
2016-03-02$6.63/sh+5,000$33,150→ 724,448 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $6.25 to $6.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.